ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 339

Toll-like Receptor Dependent Autoantigens and Vesicles from P.Gingivalis in Animal Models of RA to Modulate Collagen and Collagen Antibody Induced Arthritis

Christina Grimm1, Bianka Marklein1, Gerd Burmester1,2 and Karl Skriner3, 1Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany, 2Charité – University Medicine Berlin, Berlin, Germany, 3Department of Rheumatology and Clinical Immunology, Germany, Charité - Universitätsmedizin Berlin, Berlin, Germany

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: autoantigens, P. Gingivalis, toll-like receptors and treatment

  • Tweet
  • Email
  • Print
Session Information

Title: Rheumatoid Arthritis - Animal Models

Session Type: Abstract Submissions (ACR)

Background/Purpose A variety of animal models suggest that TLR signaling is important in the pathogenesis of RA and the generation of specific autoantibodies. This study was conducted with sera from patients with rheumatoid arthritis, as well as with arthritis animal models to identify identical autoantigens dependent on TLR 7 and 9 in human and animal models for disease modifying use. Moreover TLR2 and TLR 4 modulating bacterial vesicles from P gingivalis containing PAD (Peptidyl-Arginine Deiminase) which is involved in citrullination was used to study the TLR2/4 in arthritis.

Methods

Using protein filter technology (28000 human protein filter) the autoantigen profile of RA patients, mouse collagen and zymosan induced arthritis, as well as collagen and pristan induced arthritis in rats and TLR7, TLR9 deficient double-deficient and MyoD88 and Tir8 deficient mice of the MRL-lpr/lpr background were obtained. Cationic liposomes transferring siRNAs, bacterial vesicles, lipomannan and LPS were used for the validation of their potential as therapeutic target in collagen or collagen antibody induced arthritis (CAIA).

Results We found 18 identical proteins targeted in human and animal situations of arthritis. These data identify mRNA binding hnRNPs proteins which are part of P bodies, stress granules and components of messenger RNA stability complex as well as CRP binding proteins as target molecules in mice, rats and humans with RA. Moreover, we found MyoD88 independent autoantigens which are not expressed in the thymus or proteins such as high mobility group box proteins 1 and 2 which are MyoD88 independent sensors of nucleic-acid-mediated innate immune responses. Systemic administration of siRNAs with cationic liposomes inhibiting expression of Toll dependent autoantigens overexpressed and targeted by autoantibodies in the human and mouse synovial tissue were used for the validation of their potential to inhibit collagen induced arthritis in C57BL/6J mice. Moreover P.gingivalis vesicles containing the the PAD induce a mild inflammatory response in the CAIA model of arthritis. P.gingivalis LPS and lipomannan treated animals show a 80% reduction of athrithis score compared to E. coli LPS in a C57BL/6J CAIA model.

Conclusion

Systemic blocking of common RNA or DNA binding proteins overexpressed in synovial target tissue appears to modify arthritis. P. gingivalis vesicles evolved the ability to intercept and undermine a subset of TLR2/4 signalling events for corrupting innate immunity and modulate RA.


Disclosure:

C. Grimm,
None;

B. Marklein,
None;

G. Burmester,

AbbVie, Pfizer, Roche, UCB,

2,

AbbVie, BMS, MSD, Medimmune, Novartis, Pfizer, Roche, Sandoz, UCB,

5,

AbbVie, BMS, MSD, Pfizer, Roche, Sandoz, UCB,

8;

K. Skriner,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/toll-like-receptor-dependent-autoantigens-and-vesicles-from-p-gingivalis-in-animal-models-of-ra-to-modulate-collagen-and-collagen-antibody-induced-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology